ISSN 0303-5212
 

Original Research 


Role of fluoxetine and nortriptyline in major depressive disorders

Ghulam rasool Bhurgri, Hussain Bux Korejo, Mohammad Ali Qureshi.

Abstract
Objective
To assess the effectiveness and safety of fluoxetine and nortriptyline in major depressive disorders
Patients and Methods
This study was conducted in Sir Cowsee Jee Jehangie Institute of Psychiatry, Hyderabad in collaboration with Department of Pharmacology and Therapeutics Mohammad Medical College Mirpur Khas, from January 2009 to June 2009. Following a 1-week washout period, patients were randomly assigned to 12 weeks of parallel treatment with either fluoxetine (in a flexible daily dose of 20-80 mg) and nortriptyline (in a flexible daily dose of 25–100 mg) provided on a three times per day schedule. Clinical response was seen on weekly follow up basis.
Results
A total of 192 patients were included in this study. In the fluoxetine group, mean age was 38.2±8.8 years. In the Nortriptyline group, mean age was 39.5±11.6 years. At week-1, the gain in fluoxetine was - 55.4± 15.3 and in nortriptyline group it was - 35.4± 10.4 (P < 0.0001). Nausea and headache were common in nortriptyline 14.6% and 12.5% respectively and in Fuoxetine 4.2% and 4.2% respectively.
Conclusion
This study provides evidence in favor of efficacy and advantages of fluoxetine over Nortriptyline. Fluoxetine can be considered as first choice in pharmacological treatment of this disorder. Nausea and headache occurred more in nortriptyline than fluoxetine. (Rawal Med J 2011;36:38-40).

Key words: Depression, fluoxetine, nortriptyline, SSRI.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Ghulam rasool Bhurgri
Articles by Hussain Bux Korejo
Articles by Mohammad Ali Qureshi
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Ghulam rasool Bhurgri, Hussain Bux Korejo, Mohammad Ali Qureshi. Role of fluoxetine and nortriptyline in major depressive disorders . RMJ. 2011; 36(1): 38-40.


Web Style

Ghulam rasool Bhurgri, Hussain Bux Korejo, Mohammad Ali Qureshi. Role of fluoxetine and nortriptyline in major depressive disorders . https://www.rmj.org.pk/?mno=5746 [Access: December 07, 2023].


AMA (American Medical Association) Style

Ghulam rasool Bhurgri, Hussain Bux Korejo, Mohammad Ali Qureshi. Role of fluoxetine and nortriptyline in major depressive disorders . RMJ. 2011; 36(1): 38-40.



Vancouver/ICMJE Style

Ghulam rasool Bhurgri, Hussain Bux Korejo, Mohammad Ali Qureshi. Role of fluoxetine and nortriptyline in major depressive disorders . RMJ. (2011), [cited December 07, 2023]; 36(1): 38-40.



Harvard Style

Ghulam rasool Bhurgri, Hussain Bux Korejo, Mohammad Ali Qureshi (2011) Role of fluoxetine and nortriptyline in major depressive disorders . RMJ, 36 (1), 38-40.



Turabian Style

Ghulam rasool Bhurgri, Hussain Bux Korejo, Mohammad Ali Qureshi. 2011. Role of fluoxetine and nortriptyline in major depressive disorders . Rawal Medical Journal, 36 (1), 38-40.



Chicago Style

Ghulam rasool Bhurgri, Hussain Bux Korejo, Mohammad Ali Qureshi. "Role of fluoxetine and nortriptyline in major depressive disorders ." Rawal Medical Journal 36 (2011), 38-40.



MLA (The Modern Language Association) Style

Ghulam rasool Bhurgri, Hussain Bux Korejo, Mohammad Ali Qureshi. "Role of fluoxetine and nortriptyline in major depressive disorders ." Rawal Medical Journal 36.1 (2011), 38-40. Print.



APA (American Psychological Association) Style

Ghulam rasool Bhurgri, Hussain Bux Korejo, Mohammad Ali Qureshi (2011) Role of fluoxetine and nortriptyline in major depressive disorders . Rawal Medical Journal, 36 (1), 38-40.